Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AFIB NASDAQ:AHPI NASDAQ:MOTS NASDAQ:NMRD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAFIBAcutus Medical$0.00+10.0%$0.01$0.00▼$0.22$66K-0.5746,108 shs2,625 shsAHPIAllied Healthcare Products$0.00$0.00▼$3.46$16K-2.3951,674 shsN/AMOTSMotus GI$0.00$0.00$0.00▼$0.08$2K1.024,274 shs1 shsNMRDNemaura Medical$0.00$0.00$0.00▼$0.06$4K0.56,609 shs751 shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAFIBAcutus Medical0.00%+2,100.00%+22.22%-94.47%-92.67%AHPIAllied Healthcare Products0.00%0.00%0.00%0.00%-98.66%MOTSMotus GI0.00%0.00%0.00%+200.00%-99.41%NMRDNemaura Medical0.00%0.00%0.00%-50.00%-99.69%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAFIBAcutus MedicalN/AN/AN/AN/AN/AN/AN/AN/AAHPIAllied Healthcare ProductsN/AN/AN/AN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura Medical1.1537 of 5 stars0.03.00.04.50.01.70.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAFIBAcutus Medical 0.00N/AN/AN/AAHPIAllied Healthcare Products 0.00N/AN/AN/AMOTSMotus GI 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAFIBAcutus Medical$7.16M0.01N/AN/A($0.03) per share-0.07AHPIAllied Healthcare Products$27.05M0.00N/AN/A$1.30 per share0.00MOTSMotus GI$319K0.01N/AN/A$1.74 per share0.00NMRDNemaura Medical$3.02K1.34N/AN/A($0.41) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAFIBAcutus Medical-$81.66MN/A0.00∞N/A-272.74%-311.64%-11.57%N/AAHPIAllied Healthcare Products-$5.36M-$1.34N/AN/AN/AN/AN/AN/AN/AMOTSMotus GI-$12.87M-$15.64N/A∞N/AN/AN/AN/AN/ANMRDNemaura Medical-$14.14M-$0.39N/A∞N/AN/AN/AN/A9/29/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAFIBAcutus MedicalN/AN/AN/AN/AN/AAHPIAllied Healthcare ProductsN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAFIBAcutus MedicalN/A1.851.57AHPIAllied Healthcare ProductsN/AN/AN/AMOTSMotus GIN/AN/AN/ANMRDNemaura MedicalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAFIBAcutus Medical56.91%AHPIAllied Healthcare Products4.15%MOTSMotus GI20.06%NMRDNemaura Medical4.41%Insider OwnershipCompanyInsider OwnershipAFIBAcutus Medical5.21%AHPIAllied Healthcare Products5.10%MOTSMotus GI0.34%NMRDNemaura Medical40.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAFIBAcutus Medical34029.78 million28.23 millionOptionableAHPIAllied Healthcare Products1504.01 million3.81 millionNot OptionableMOTSMotus GI305.77 million5.75 millionNot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataNMRD, AHPI, AFIB, and MOTS HeadlinesRecent News About These CompaniesNMRD Nemaura Medical Inc.June 18, 2025 | seekingalpha.comNemaura Medical (OTC:NMRD) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comNemaura Medical Inc (NMRD)May 26, 2024 | investing.comNXNN Nexeon Medsystems IncMay 24, 2024 | seekingalpha.comNemaura Medical Stock (OTC:NMRD) Earnings Dates and Earning CallsFebruary 23, 2024 | benzinga.comMaxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ETJanuary 22, 2024 | finance.yahoo.comNemaura Medical, Inc: Important Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finanznachrichten.deImportant Update on Listing Status and Strategic DirectionJanuary 3, 2024 | finance.yahoo.comBuy Rating Affirmed for Nemaura Medical on sugarBEAT Prospects and Market ExpansionDecember 20, 2023 | markets.businessinsider.comNemaura Medical: Regulation Fd Disclosure, Financial Statements And ExhibitsDecember 15, 2023 | cbonds.comCNemaura Medical, Inc: Nemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finanznachrichten.deNemaura Medical Inc. Receives Positive Nasdaq Listing DecisionDecember 13, 2023 | finance.yahoo.comNemaura Medical (NMRD) Price Target Increased by 54.55% to 8.67November 27, 2023 | msn.comNemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic GrowthNovember 21, 2023 | finance.yahoo.comNemaura (NMRD) to Expand in UK With Metabolic Health ProgramNovember 17, 2023 | msn.comNemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)November 16, 2023 | finance.yahoo.comNemaura Medical, Inc: Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business UpdateNovember 15, 2023 | finanznachrichten.deAcutus Medical Non-GAAP EPS of -$0.52, revenue of $5.2MNovember 14, 2023 | seekingalpha.comNemaura Medical, Inc: Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 14, 2023 | finanznachrichten.deNemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss DrugsNovember 14, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNMRD, AHPI, AFIB, and MOTS Company DescriptionsAcutus Medical NASDAQ:AFIB$0.0022 +0.00 (+10.00%) As of 07/14/2025 10:44 AM EasternAcutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.Allied Healthcare Products NASDAQ:AHPIAllied Healthcare Products, Inc. engages in manufacturing respiratory products used in the health care industry in hospitals and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. Its product line includes respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.Motus GI NASDAQ:MOTS$0.0003 0.00 (0.00%) As of 07/14/2025Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Nemaura Medical NASDAQ:NMRD$0.0001 0.00 (0.00%) As of 07/14/2025 01:07 PM EasternNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters 3 Analysts Set $600 Target Ahead of Microsoft Earnings JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth NVDA Greenlight: China H20 Sales Spark 50% Rally Potential Tesla: 2 Plays Ahead of Next Week's Earnings Report New Catalyst Sends Joby Stock to 52-Week Highs Palantir Gets Price Hike From Wedbush Amid High Valuation Delta Air Lines Stock Rallies on New Guidance—Can It Keep Going? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
